What Happened?
Seattle, -based CTI-BioPharma Promoted Corey Masten-Legge as Vice President of Legal Affairs and Chief Compliance and Risk Officer
About the Company
CTI was founded on the belief that a coalition between unique scientific technology and its strong desire to “do right” by the patient could help us achieve our mission to acquire, develop and bring to market less toxic, more effective therapies to treat and cure cancer. We strive to do business better than other biopharmaceutical companies. Better means a more collaborative, well-trained team environment willing to institute novel approaches to scientific discovery and business opportunities. A willingness to push the limits to achieve challenging goals is the essential attribute that sets CTI employees apart.
About the Person
Corey Masten-Legge is Vice President of Legal Affairs and Chief Compliance and Risk Officer at CTI BioPharma. Previously, Corey held various senior legal leadership roles in the industry.
Info Source
News
Short Profile